GlaxoSmithKline extends SAP contract with Mahindra Satyam

09 Jul 2009

Be the first to comment

A Computing logo
CP Gurnani
Gurnani: "We are thankful to GSK for having reposed its faith in us"

GlaxoSmithKline (GSK) has signed a five-year, multimillion-dollar deal with Indian IT service firm Mahindra Satyam for the support of the pharmaceutical giant's SAP-based systems and other critical software worldwide.

This is the first significant deal after the Satyam scandal that led to the firm being acquired by Tech Mahindra, and is an extension of a seven-year relationship which covered the provision of IT application development and support services.

Further reading

"GSK is delighted to be able to extend its contract for another five years. We look forward to continuing to receive the high level of professionalism and commitment from Satyam and its associates that we have experienced over the past seven years,” said Bill Louv, GSK chief information officer.

Mahindra Satyam’s new chief executive CP Gurnani said the deal reflects “the competitive spirit and resolve of the associates” in the supplier.

“This is a reflection of the fact that we are well on our way to regaining our position as a market leader and we are thankful to GSK for having reposed its faith in us,” said Gurnani.

Read an exclusive Computing interview with Mahindra Satyam’s Gurnani and his hopes for the future here.

Reader comments

Have your say on this article

All fields required. Your email address will not be displayed on the site.

By submitting a comment you agree to abide by our Terms & Conditions

  • Digg
  • Tweet

Newsletters

Sign up for our FREE newsletters

Technology Patent Wars

Large companies such as Microsoft, Facebook and Google have been hoovering up technology patents recently. Is this stifling innovation?

87 %

5 %

8 %